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Abstract
In an attempt to promote patient agency and foster more egalitarian relationships between 
patients and doctors, discourse concerning health and wellbeing in the UK has increasingly 
centred around the notion of informed and ‘expert’ patients who are able to effectively input 
into  the  direction  and  management  of  their  own  health  care  and  treatment.  While  the 
relationship  between  a  patient  and  their  doctor  can  play  a  vital  role  in  influencing  the 
treatment decisions and health-related outcomes of people living with long term illness, little 
is known about the ways in which people living with HIV actually perceive their relationship 
with their doctors, nor the implications this may have for the types of treatment they may seek 
to use and the related information that they share. Drawing on research undertaken amongst 
HIV positive migrants from southern Africa living in the UK, this paper argues that patient-
doctor relationships can be heavily influenced by the perceived legitimacy of different forms 
of medical  knowledge and treatments  and by culturally influenced ideas regarding health, 
wellbeing and agency. Despite a desire amongst some migrants to use ‘traditional’ medicines 
from southern Africa as well as other non-biomedical treatments and therapies, the research 
found  that  the  perceived  lack  of  legitimacy  associated  with  these  treatments  in  the  UK 
rendered their use a largely clandestine activity. At the same time, many patients made clear 
distinctions concerning issues affecting their immediate health and factors influencing their 
more general wellbeing, which in turn, impacted upon the information that they chose to share 
with, or conceal from, their doctors. Such findings challenge assumptions underpinning policy 
promoting patient agency and have significant and, in cases, potentially adverse implications 
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for the safety and effective administration and management  of HIV treatments in African 
migrant populations and possibly more generally. 
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Introduction
For the last twenty years, sexual health promotion and HIV prevention in the UK has, in large 
part, been premised on the assumption that biomedical and science-based understandings of 
illness  form  the  framework  within  which  treatment  seeking  and  treatment  management 
decisions are made (Johnson, Mercer, & Cassell, 2006). Such approaches imply people will 
act in a rational and responsible manner to maximize their opportunities for securing effective 
biomedical treatment (Schoepf, 2004) whilst giving little recognition to the broader social, 
cultural and economic context within which treatment seeking and management decisions are 
made (Kesby, Fenton, Boyle, & Power, 2003; Imrie, Elford, Kippax, & Hart 2007). Recently 
however, attempts have been made within the UK health sector to move away from a purely 
science-based biomedical model of disease, to acknowledge and explore the more subjective, 
social  and  cultural  dimensions  of  illness  as  they  are  experienced  by  people  who  are 
themselves  living  with  ill  health  (Whelan,  2009).  In  seeking  to  better  understand  such 
experiences, particular attention has been paid to the role of ‘illness narratives’ (Kleinman, 
1988;  Garro & Mattingly, 2000) which reflect socio-cultural understandings and values and 
through  which people can obtain or assert particular social identities, communicate what is 
significant in their lives, make sense of illness through a narrative structure (Mattingly, 1994) 
and, where necessary, re-establish some degree of order and continuity to the ‘biographical 
disruption’ which may be caused by ill health (Bury, 1982). 
As Frank (1997) explains, different versions of the narratives of those living with ill health are 
influenced by who is being told, when and where, and what is or is not deemed appropriate to 
tell. Directly, inter-related with this, it is now well recognised that effective communication 
between  patients  and  their  doctors  is  fundamental  in  helping  influence  positive  health 
outcomes (Ong, de Haes, Hoos, & Lammes,  1995; Charles, Gafni, & Whelan, 1997). In the 
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UK, the idea of ‘resourceful’ (Muir-Gray, 2001), ‘autonomous’ (Coulter, 2002) and ‘expert’ 
patients who are able to input effectively into the control and management of their own health 
care  has  been  at  the  forefront  of  government  policy  on  health  since  the  late  1990s  (cf. 
Department  of  Health  1999;  2001).  Encouraging  the  promotion  of  patient-doctor 
‘partnerships’, such approaches have played a key role in focusing attention on encouraging 
patient judgement, agency and empowerment in the health care process. 
Such  initiatives,  in  which  patients  are  frequently  recast  as  ‘service  users’  or  ‘clients’, 
undoubtedly appear to be well intentioned in reshaping power relations within the health care 
system. However, using research undertaken with migrants from southern Africa living with 
HIV in the UK, this paper seeks to add to debates regarding doctor-patient partnership models 
by  exploring  how  multiple  meanings  and  practices  of  health  and  treatment  can  shape 
communications within the clinic. The paper argues that patient agency can itself be heavily 
influenced  by  wider  ideas  about  individual  responsibility,  the  perceived  legitimacy  and 
effectiveness of different types of health care and treatment, and ideas about what kinds of 
information  should or should not be shared with medical  professionals.  Placing particular 
focus upon medical knowledge, patient use of ‘traditional’ and ‘alternative’ medicines and 
treatments,i and  ideas  about  health  and  wellbeing,  it  is  argued  that  while  patients  are 
encouraged to ‘take control’ of their health care, wider structures and norms which govern 
dominant ideas about health and wellbeing can continue to both produce and constrain their 
actions and push less ‘acceptable’ and regulated ideas and behaviours underground. This not 
only calls  into  question the degree  to  which the promotion  of  patient  agency reflects  the 
empowerment  or  constraint  of  individual  health  care,  but  also  highlights  the  potentially 
adverse implications  which can result  for individual  and public  health  when the effective 
administration  of  life  prolonging  treatments  are  compromised  by  disjunctures  between 
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individual beliefs and desires and pressures to be seen to be complying to wider and more 
‘acceptable’ health care agendas. 
Knowledge and legitimacy in health care encounters
In an age in which one in every three people in the UK is living with a chronic illness or 
disability (Wilson, 2001), and can only manage rather than cure their condition, the idea of 
developing patient resourcefulness and expertise seems logical. However, it is increasingly 
acknowledged that such approaches tend to overlook deep-rooted professional power and the 
structural constraints which govern resource accessibility (Tang & Anderson, 1999; Cant & 
Sharma, 1999; Wilson, 2001; Fox, Ward, & O’Rourke,  2005). Whilst asserting that those in 
positions  of  recognised  expertise  have  the  authority  and  power  to  regulate  behaviour,  a 
Foucauldian interpretation of power relations within medical encounters also recognises that 
self-surveillance carried out by individual patients as well as processes of socialisation which 
foster respect for the knowledge of those in positions of authority can influence individual 
health  seeking  behaviour  (Wilson,  2001;  Lupton,  2007).  Perhaps  paradoxically  therefore, 
encouraging patient agency in health care assumes both a level of compliance to accepted 
(usually biomedical)  agendas  and a level  of  autonomy in the pursuit  and management  of 
health care and treatment,  both of which can present particular challenges to patients and 
health practitioners. 
One such challenge concerns decision making over treatment seeking and adherence and the 
information on this that patients are willing to share with health professionals.  Despite the 
increasing popularity of alternative treatments and therapies in the UK in recent years, there 
remains a tendency for dominant health discourse to view the use of biomedical treatments as 
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constituting  rational  and  responsible  behaviour.  As  such,  the  use  of  non-biomedical 
treatments  and therapies  are  reportedly viewed by some health  professionals  as  somehow 
illogical and deviant, and as behaviour that still needs to be supervised and managed from 
within the biomedical sector (Cant & Sharma, 1999; Cohen, McCubbin, Collin, & Pérodeau, 
2001; Keshet, 2009; Broom & Adams, 2009). 
Research suggests that this is particularly apparent in relation to HIV, where the development 
and availability of potent anti-retroviral combination therapies has focused attention on the 
‘technologization’  of  HIV care  and the  ability  of  clinicians  to  manage  the  course  of  the 
infection (Yallop, Lowth, Fitzgerald, Reid, & Morelli, 2002; Gold & Ridge, 2001; Persson 
Race, & Wakeford, 2003; Rosengarten, Imrie, Flowers, Davis, & Hart, 2004; Davis, Frankis, 
& Flowers, 2006). With such significant biomedical advances being made in recent years, 
non-consistent use of anti-retroviral therapy (ART), and use of other forms of non-biomedical 
treatment can be interpreted from within the health sector as a combination of ‘incompetent’ 
doctors  and  ‘failing’  (Green  &  Smith,  2004)  and  ‘desperate’  (Broom  &  Adams,  2009) 
patients. However, such understandings  overlook the broader socio-cultural contexts within 
which such treatments are used (Wong & Ussher, 2008; Schumaker & Bond, 2008), and the 
ways in which the meanings and values people invest in different treatments and medications 
can influence treatment uptake and consistency (Persson, 2003; Del Casino, 2004; Reynolds 
Whyte, van der Geest, & Hardon, 2007; Helman, 2007). As Van der Geest, Reynolds Whyte 
and  Hardon (1996,  166)  state,  “rarely  is  noncompliance  [with  medications]  the  result  of 
patients  misunderstanding  the  doctor’s  information,  but  it  is  the  result  of  patients  having 
different  ideas  and,  in  particular,  different  interests.”  Such issues  are  perhaps  particularly 
pertinent  amongst  migrants  in  the  UK  for  whom  understandings  of  health,  illness  and 
treatment may more commonly fall outside of the biomedical parameters which underpin the 
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National  Health  Service  (NHS).  Indeed,  as  Green,  Bradby,  Chan,  and  Lee  (2006,  1499) 
explain, despite some efforts to make the NHS more equitable and inclusive, the promotion of 
different  ideas  about  health  have  been  sporadic  and  have  often  tended  to  “downplay  or 
pathologise black people’s cultures whereby ethnic minorities are constructed as dangerous to 
their own health.” 
This is of considerable significance in the case of HIV, since it affects  a disproportionate 
number of black African migrants in relation to the white population of the UK, and requires 
adherence  to  carefully  monitored  and  individualised  anti-retroviral  treatment  regimens  in 
order to help prevent the development of drug resistant strains and ultimately, death. At the 
same time, delays in getting affordable and consistent sources of ART to many parts of Africa 
have meant that historically, relatively few people from affected countries have been able to 
rely  upon  such  forms  of  biomedicine  and  have  been  placed  in  situations  in  which  it  is 
arguably entirely rational to seek out alternative forms of treatments. Indeed, such treatments 
are often integral to African cosmologiesii which regard many types of ill health as having 
environmental or spiritual, rather than purely biomedical aetiologies, and many of which have 
been found to be effective in peoples’ own or shared experiences via the provision of physical 
and/or psychological relief. As Kremer and Ironson (2006, 520) state, “Writing prescriptions 
is easy but in the end, regardless of what the physician wants, the patient makes the ultimate 
decision whether or not to take ART.” This paper argues that such factors are influenced by a 
constellation of discourses and practices which shape migrants’ agency in health seeking. The 
paper thus seeks to examine the factors which influence the relationship between HIV positive 
migrants  from southern Africa and their  doctors,  and to provide insight into the potential 
implications of these relationships for treatment seeking and consumption. 
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Methodology 
This research was undertaken as part of a larger study on treatment seeking and treatment 
management amongst migrants from southern Africa living in London. Ethical approval for 
the study was obtained from the East London and The City Research Ethics Committee and 
the Institute of Education, University of London, and informed consent was obtained from all 
informants prior to participation. This paper draws upon data obtained through eleven focus 
group discussions held with seventy migrants from Zimbabwe (n=39), Zambia (10) and South 
Africa  (21),  thirty  nine  of  whom  were  women  and  thirty  one  men,  and  twenty  repeat 
interviews  (a  total  of  forty  interviews)  held  with  migrants  from these  countries  (twelve 
women and eight men). At the time of the study, interview participants were accessing HIV 
services at a London hospital. 
The aim of the focus group discussions was to gain insight into people’s understandings and 
experiences of health care services in the UK and in their home country, and their access to, 
and use of, biomedical, alternative, and traditional sources of treatment. Selection criteria for 
participation  included coming to the UK as a  migrant  from Zimbabwe,  Zambia  or  South 
Africa, living in London and being aged over 18. Five of the groups were single gender, and 
six were mixed, according to participants’ preferences. The location of each discussion was 
decided upon by group participants and included community group centres, peoples’ homes 
and rooms within the university in which the lead researcher was based.  Each discussion took 
between two and five hours, was tape recorded (with permission) and transcribed verbatim.  
Most participants from Zimbabwe and Zambia were accessed via community support groups 
and had arrived in the UK within the past decade. Those from South Africa and those who 
had been in the UK for longer time periods and were not making use of community groups 
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were accessed via more informal social networks e.g. via friends of key contacts. Many of 
those who had arrived in the UK from Zimbabwe in the past decade had applied for asylum in 
the UK. A number of the Zambians and South Africans had applied for leave to remain on 
compassionate grounds, having first arrived in the UK on study or work visas. 
At a later stage of the research, repeat interviews were undertaken with twenty migrants from 
Zimbabwe (n=10), Zambia (n=8) and South Africa (n=2) who were accessing HIV support 
services via a major London hospital.iii Participation was on a voluntary basis and interviews 
were undertaken in a location of the participant’s choice (usually in a non-clinical setting in 
the hospital,  at the person’s home or at the university).  An interview guide approach (see 
Kitchen and Tate, 2000) was used, enabling flexibility in wording and ordering of questions, a 
more conversational form than that offered by structured interviews, and the possibility of 
following up new issues as they were raised. Interviews were tape recorded (with permission) 
and transcribed verbatim by the lead author. The purpose of these interviews was to gain 
insight into the ways in which social, cultural and economic factors had influenced people’s 
understandings of their health prior to, and since their HIV diagnosis, and how such factors 
had oriented them towards seeking particular types of treatment. Particular focus was placed 
upon the relationship that patients held with health providers such as HIV clinicians and GPs 
and the ways in which these relationships influenced the kind of treatment that people sought, 
and the kind of information that they chose to disclose to them. 
It is likely that the lead researcher’s previous experience of working in southern Africa and 
with migrants in the UK played a role in facilitating the discussions. However, the fact that 
she also had non-clinical  status and was able to ask questions which drew upon peoples’ 
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experiences beyond their encounters with biomedicine are likely to have helped to open up 
spaces for discussion on what are, potentially, sensitive issues. 
Communicating with HIV clinicians
Almost all of the participants involved in interviews in this study commented on the high 
level of trust and respect that they held for their HIV clinicians. In most cases, people had 
been seeing the same doctor since their initial diagnosis, a factor that had helped them to build 
up a relationship that they regarded as solid and dependable. As has been reported elsewhere 
(cf.  Horne,  Cooper,  &  Fisher,  2008),  a  number  of  patients  felt  that  the  expertise  and 
experience of their physicians made them best placed to advise them on their treatment, and 
as such, they were happy to take their recommendations with little question. This was most 
often the case amongst those who had come from relatively ‘westernised’ backgrounds and 
had primarily used biomedical treatments for illness whilst in Africa. However, it was also 
reported amongst several people who, at HIV diagnosis, were already extremely sick with an 
AIDS-defining illness. In these cases, individuals felt that the knowledge, expertise and care 
provided  by their  doctors  had  been the  major  factor  in  their  survival,  and as  such,  they 
reported placing ultimate faith in them. The competence of doctors was also judged by the 
perceived  quality  of  their  technical  and  inter-personal  skills,  with  those  seen  to  be 
commanding respect from other health workers viewed as being the most capable. 
While some people were willing to follow their doctor’s advice with little question, most of 
those interviewed were keen to take a considerable level of responsibility for their health care 
and treatment.  Indeed, some people reported that their  HIV clinician had actually made a 
point of emphasising that they, as patients, played the most important role in the success of 
their own treatment and health since they were the only ones who could guarantee that they 
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would  take  their  anti-retroviral  medications  as  they  should.  For  some  people,  this  also 
involved  proactively  seeking  information  on  biomedical  treatments  that  they  had  been 
prescribed, and taking the initiative to discuss biomedical treatment options with their doctors 
whenever  the  opportunity  arose.iv However,  others  cited  a  number  of  factors  which 
constrained their  ability  and willingness  to  share their  thoughts  over,  and experiences  of, 
treatment taking with their doctors. 
One such issue was the reported tendency amongst some doctors to use medical terminology 
that was considered too complicated or inaccessible to understand. Talking about encounters 
with his HIV doctor when he started taking ART, a Zambian manv explained how confusing 
he had found the experience and how he did not feel that he was in a position to make a fully 
informed decision over the treatment.
There was a language that they were speaking that I didn’t understand – the viral load, 
CD4 count – these were things that they could understand but I couldn’t understand. So it’s 
like what is a CD4 count, what is a viral load, how do the two behave? They were saying 
this  is  too  low,  this  is  too  high  –  but  they  were  speaking  a  language  I  couldn’t 
understand…..I’ve had a choice [over treatments] but to be quite honest it’s quite difficult 
to  make  the  choices  because  the  language  that  is  spoken with  the  treatment  is  a  new 
language. Even though they say you can try this or this, they are talking about M1, M4, 
M25 – you feel like saying’ just tell me what I’ve got’.……even the leaflets, there are 
certain words in there that you have to go in a dictionary to find to understand it…..They 
won’t come to do it in a language that you can understand because that is the language that  
they know…..that medical language defeats you. I’m lucky, I’m only on two tablets, but 
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for people who are on more, to explain to them what each tablet does to you – you can say 
‘yes, yes’, but to be honest, I might have understood, but not fully. 
(M7, Zambian)
When  asked  why  he  had  not  requested  that  the  doctor  explain  his  treatment  in  a  more 
accessible manner, the informant’s response was typical of the majority of those interviewed 
who felt that the doctors had too many other important issues to attend to, to have to answer 
‘foolish’ questions from patients.
If someone is telling you this is A, B, C, and you keep asking the same questions, you will 
feel a fool. I’d love to ask questions but I don’t want to bore someone in trying to learn. 
I’m not a doctor and I haven’t reached that level where there will be a language they will 
speak that I will really understand. 
(M7, Zambian)
Partly as a result of these gaps in communication, tensions in the patient-doctor relationship 
were also reported when doctors were keen to move patients on to different treatments. In all 
such cases, patients acknowledged that the new medications they were being transferred to 
were considered by health professionals to be more advanced than their existing treatments. 
However, several people commented that they did not feel that it was necessarily in their best 
interests to change treatments, but that they had not had the opportunity to discuss the options 
fully with their doctor. F8 (a Zambian woman) for example, had been put onto a combination 
therapy which meant that she only had to take one, rather than two tablets each day. However, 
she reported feeling much more comfortable taking the tablets separately since she felt better 
able to monitor the effects of each drug individually. Similarly, M5, a Zimbabwean man, was 
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particularly  aggrieved  to  find  that  his  treatments  had  been changed without,  he  felt,  him 
giving his consent. In this case, he commented that the desires of the doctors to pursue more 
advanced medications and make the treatment ‘easier’ to take had taken precedence over his 
own wishes and his knowledge of the way that his body worked. 
I’m a bit angry because when I spoke to my consultants last year,  they said they were 
going to  keep me  on the existing  drugs  but  add another  one.  And my viral  load  was 
undetectable. But when the new consultants came in, they said they wanted to change them 
to make my treatment  easier.  But I said ‘I’m not complaining’  – but they kept saying 
‘easier, easier’. …Now they are telling me that they want to make it easier because it has 
worked for other patients – I am not those other patients.
(M5, Zimbabwean)
Although almost all of those interviewed placed faith in their HIV doctor as an individual, a 
number of people raised more fundamental concerns regarding the intentions of the health 
service  more  broadly.  Some  participants  felt  that  their  status  as  migrants  made  them 
particularly vulnerable to exploitation by the health sector and voiced their suspicions that 
they  were  being  used  as  guinea  pigs  in  biomedical  trials.  This  was  particularly  evident 
amongst participants from South Africa, where health issues have historically been strongly 
associated  with  apartheid,  exploitation  and  exclusion.  As  the  following  discussion 
demonstrates,  it  was apparent  that  such perceptions  could directly  influence  the way that 
people related to health professionals, the information that they were willing to share with 
them and the repercussions of this for treatment adherence and treatment seeking outside the 
biomedical sector. 
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In certain circumstances, they [people with HIV] know that they are being put on trials 
without anyone talking to them. Because when they go out and they say at a support group 
which medicines they are taking – and they are the only one taking this, then they will be 
asking ‘why?’  Then they think they are on trials  because when it  happens it  brings  a 
question mark. The other thing is that when people are on medication they are listening to 
their bodies, and you go to the doctor and say this is what is happening –some doctors 
don’t listen. The patient will tell them this is how I am feeling, can I change the regime and 
they will say ‘no, no, no’ and they will insist that you stay on that. Now if that person goes 
home a lot of things are going on in their heads. They think; I am telling my doctor but he 
is not listening to what I am saying. Maybe that person is an asylum seeker so he can’t 
stand and fight with the doctor. So, what he will do is maybe he will stop [the treatment] or 
maybe start looking for alternatives. But meanwhile, when they go to the hospital they will 
keep quiet and the hospital will keep recording false data because that person is not taking 
the medication. So, that way the trust between the patient and the doctor comes under quite 
a big question mark because the doctor is not really listening to the patient.
(South African man, mixed gender focus group)
Some people felt that a further obstacle to effective communication could occur when doctors 
were caught up in wider health care agendas which promoted certain types of medications in 
the interests of the pharmaceutical industry. For a number of people (particularly people from 
South  Africa  and  some  Zimbabweans),  this  was  interlinked  with  an  underlying  belief  in 
conspiracy theories in which the transmission of HIV and the testing of drugs were seen as 
part of a ‘western’ agenda to control and exploit people in developing countries (for a more 
detailed discussion of these issues see Niehaus with Jonsson, 2005). For others such as M1, a 
Zimbabwean man, it was also considered to result from an attitude amongst health providers 
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in  the  UK  that  continues  to  treat  biomedical  knowledge  as  superior  to  other  forms  of 
understanding such as traditional treatments from Africa.
The NHS, it’s okay. But they are in a situation where they believe that only one type of 
medication works because they can define it themselves. It’s a sort of unidirectional way 
that somehow they have convinced themselves that what they don’t understand is wrong. 
And then they define normality in terms of what they themselves understand. Which is 
nonsensical because actually, these people who are using these other things [other forms of 
medication], they lived for millennia without the medications that you are using over here 
and they didn’t suddenly die, they are not extinct.
(M1, Zimbabwean)
Use of non-biomedical treatment 
It is increasingly recognised that some non-biomedical treatments can provide physical and 
psychological benefits in terms of health and wellbeing. However, it is also acknowledged 
that the interactions between some types of herbal and pharmaceutical medicines can have 
significant,  and potentially adverse repercussions for the health outcomes of people taking 
HIV anti-retroviral treatments (Schumaker & Bond, 2008; Mills, Montori, Perri, Phillips, & 
Koren,  2005a)  and  indeed,  that  the  claims  supporting  some  such  ‘remedies’  are  highly 
debatable. Research has found that a significant proportion of people use traditional and/or 
alternative  treatments  for  HIV  either  instead  of,  or  in  combination  with  anti-retroviral 
medications (Pawluch, Cain, & Gillett, 2000; Owen-Smith, Diclemente, & Wingood, 2007; 
Littlewood  &  Vanable,  2008).  In  the  present  study,  forty  five  per  cent  (45%)  of  those 
participating in interviews reported using some form of non-biomedical treatment before they 
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had  started  taking,  and/or  in  combination  with,  their  anti-retroviral  treatment  (ART).  In 
addition,  75%  claimed  that  they  would  like  to  use  non-biomedical  treatments  either  in 
combination with, or as alternatives to ART if they were able to access them. 
All  of  those  concerned  were  keen to  try  other  treatments  to  improve  their  health  status. 
However, as has been reported elsewhere (cf. Doyal and Anderson 2005; Doyal, Anderson 
and Paparini, 2009), reliance upon ART was also found to lead to some people feeling that 
they were ‘trapped’ in the UK. Many people interviewed were therefore keen to try other 
treatments which, if successful, would enable them to return to their home country.  More 
women than men reported having used such treatments, although similar proportions of men 
and women expressed a wish to use them. The desire to use such treatments did not appear to 
be heavily influenced by age, level of education or time spent in the UK.vi However, it was 
more commonly felt (in both interviews and focus groups) amongst those who had grown up 
in  families  which  had  used  such  treatments  (often  ‘traditional’  African  treatments),  the 
majority of whom had been based in rural areas. Although people from all three countries 
reported  using,  or  wishing  to  use,  non-biomedical  treatments,  it  was  particularly  evident 
amongst those from the Kwa Zulu Natal area of South Africa and the Matabeleland area of 
Zimbabwe, where such practices were reported to play an important role in health seeking 
culture. 
In  line  with  previous  research,  (cf.  Kremer  &  Ironson,  2006;  Peltzer  Friend-du-Preez, 
Ramlagan, & Fomundam, 2008), few people had fully disclosed to their doctors their use of, 
or intentions to use other treatments. A number of key reasons were given for this. First, some 
respondents stated simply that they did not recall their doctor ever asking them about their use 
of other treatments, or that they had only done so when they had first started taking ART. 
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Secondly, it was generally felt by both focus group and interview participants, that using non-
biomedical treatments – particularly those which had been sourced from Africa, would be 
frowned upon by HIV doctors in the UK, and would open the patient up to a level of shame, 
embarrassment and rebuke. It was common for people to comment that openly using such 
treatments  when  access  to  more  advanced  biomedicine  was  freely  available  would  be 
interpreted  as  foolish,  naïve,  and  irresponsible,  even  when  they  themselves  placed 
considerable faith in non-biomedical treatments that they had used whilst in Africa. Rather 
than risk this humiliation, some people had decided that they would not broach the subject 
with  their  doctor.  F7,  a  Zimbabwean  woman,  for  example,  had  been  taking  a  series  of 
different herbal medicines which had been sent to her by a traditional healer in Zimbabwe. 
Although she reported becoming increasingly unwell as a result of using these treatments, she 
did not report this to her doctor, stating 
I  didn’t  talk to them about  what  I  had been taking because I  was so embarrassed…..I 
believe  that  if  you  are  talking  to  someone  who  is  educated  medically,  they  won’t 
understand – ‘you are using herbs, what do you need to use herbs for?’ So I thought they 
wouldn’t understand why I wanted to use the herbs, what I was going to use them for. So 
that’s why I didn’t tell them.
(F7, Zimbabwean)
A major issue raised by respondents was their inability to ‘prove’ to doctors that treatments 
that they obtained from Africa were effective. However, it was frequently commented that 
unlike Chinese medicine which was well documented and as such, relatively well accepted, 
treatments  from  Africa  were  rarely  researched,  resulting  in  ill  informed  preconceptions 
regarding their safety and utility.
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A further reason for not discussing the use of such treatments was the fear that doctors would 
attempt to stop the person from taking them even though the patient themselves felt that they 
were of benefit to their health. In order not to upset or offend their doctor by going against 
their wishes, therefore, a number of people felt that it was best just not to mention such things  
in the first place. Other informants such as F4 and M4, explained that if they ever did discuss 
their use of, or intentions to use, non-biomedical treatments, they would first gauge the mood 
of their doctor and then wait to broach the issue when the doctor appeared to be in a receptive 
frame of mind. In addition, they commented that they would read up on the treatments that 
they wished to take so that they could go to their doctor fully armed with evidence supporting 
its efficacy. This was considered especially important when dealing with those doctors who 
were reputed to be particularly disapproving of non-biomedical treatments.
You know, I like the doctor very much, but I have to find ways to get to her – I don’t just  
bring things up – I have to see her state of mind that day, and if she is happy and chatty 
then I can bring up the situation with her and we can talk about it. If she is in a bad mood, I 
save it for another time.
(F4, Zimbabwean)
Normally I’d research it first and before I saw the doctor I would print off information 
written by other doctors and then ask him what he thinks about it.
(M4, Zambian)
With most patients only attending appointments with their HIV doctor every three months, 
however, there was often a considerable time lag between people trying new treatments and 
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finding an opportunity to discuss this with their doctor and in some cases, it is possible that  
this may have risked compromising the effective use of their anti-retroviral treatments. 
The uptake of non-biomedical treatments was also not generally discussed when patients did 
not feel that it was necessary to inform their doctors of their use. This was usually the case 
when  people  were  taking  various  types  of  non-prescription  supplements  and  immunity 
boosters that they had purchased in the UK or via websites, or when products such as Aloe 
Vera were deemed by informants to be so ‘natural’  that they could not pose any form of 
health risk. In such cases, most people concerned felt that because these treatments had come 
from the UK or via ‘official’ websites, they were more likely to be acceptable to their doctors  
than ‘traditional’ treatments sourced from Africa. The fact that many of these treatments were 
also available  in tablet  or  bottled  form (rather  than as  raw or  semi-processed herbs) also 
helped people to legitimise their use, since it implied that they had been ‘measured’ and were 
regulated  by  officially  ‘approved’  health  professionals.  As  such,  a  number  of  people 
explained that they had not felt that these products were likely to interact negatively with their 
ART and that it  had not occurred to them to discuss the use of these products with their  
doctors. 
At the same time however, some people felt that the legitimate nature of these treatments 
meant  that  it  would  be easier  to  discuss  their  use with a  doctor  should they ever  feel  it 
necessary to do so. One woman patient on ART for example, explained that she was seeking 
to also use Mariandina, a herbal product that its makers claim helps maintain good general 
health,  boosts  immunity  and  can  help  treat  certain  HIV-related  conditions  such  as 
tuberculosis,  herpes  zoster  and  Karposi’s  Sarcoma  (see  Mariandina  Nutritional  Health 
Products  2009).vii In this  case,  the patient  felt  that  she might  discuss with her  doctor  her 
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intentions to use this product because Mariandina was itself made by a medical doctor (albeit 
a controversial oneviii).
Maybe because it was invented by a medical doctor they [her doctor] will understand what 
I am saying about it. It’s different from me coming in with a package with some powder in 
it [i.e. herbal medicines from Africa] which no-one will understand. Maybe they will think 
that it was invented by a medical doctor, he knows what he is doing.
(F4, Zimbabwean)
Distinctions drawn by patients regarding issues affecting their health and issues affecting their 
more general well-being were also found to influence the kind of information that was shared 
with  their  treating  HIV  physician,  and  demonstrate  that  dominant  cultural  ideas  and 
expectations  regarding gender  and identity  are  key components  which  need consideration 
when exploring the constitution of patient agency. One woman, for example, had been using a 
range of herbal medicines from Zimbabwe and from African markets in London to try to 
make herself more fertile. While she reported that she had found these medicines helpful in 
‘washing out’ her stomach and her blood by bringing on diarrhoea and vomiting, she said that 
it had not occurred to her to discuss their use and the potential for negative interaction with 
her HIV treatments with her doctor because she viewed her fertility as a private issue, rather 
than an issue that was directly connected to her health status. 
Similarly,  a  significant  proportion  of  focus  group  participants  and  a  number  of  those 
interviewed reported using herbal ‘love potions’ sent from southern Africa to attract partners 
and to enhance their sex drive and performance. Such potions are usually ingested and taken 
on a regular basis and as such, have the potential to interact with biomedical HIV treatments.  
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However, none of the people who reported taking them had discussed their use with their 
doctor, seeing this as an issue that fell firmly outside the bounds of what could or should be 
discussed with a health practitioner. When asked whether he would talk about his use of love 
potions with his doctor, M4 stated,
It’s a hard question because this is about someone’s feelings. If you get a woman and you 
feel you are not performing well sexually and you want to make this lady happy, I don’t 
think that you are going to think first, well let me talk to my doctor! Because if they stop 
you and you really want this lady – that’s a big question mark. 
(M4, Zambian)
None of the research participants claimed to know exactly what was in these substances, and 
the present study did not involve any form of scientific analysis of their content. The potential 
for adverse interactions between such ‘treatments’ and ART is not therefore known. However, 
a  number  of  participants  themselves  acknowledged  their  concerns  over  the  use  of  such 
potions, stating that there was a temptation to take them in large and unregulated amounts to 
ensure their efficacy. 
We tend to use these things in greater quantities to make sure it works. You might take it 
every day and you’d use a tablespoon instead of a teaspoon. All we might know is that it  
has come from this tree – but a tree has so many properties in it that you don’t know what  
you are taking…….It’s not as if you actually see someone going to the tree to get this thing 
– so it could be anyone getting anything from any tree. These things are not done out in the 
open so that’s another reason why people don’t talk about these things with their doctor – 




For the past decade, health care policy in the UK has made steps to promote patient agency 
and to reshape the power relations between doctors and patients. Ideas inherently linked to the 
notion of patient-doctor partnerships clearly imply the need for a significant level of mutual 
respect,  openness,  trust  and good communication  between both parties  in  the  health  care 
process.  However,  the  findings  from  this  study  challenge  the  extent  to  which  such 
restructuring  is  achievable  or  necessarily  desirable  when  prevailing  ideas  about  agency, 
medical knowledge and the legitimacy of various types of treatment continue to be perceived 
by patients as endorsing the dominant position of biomedicine. 
In the research reported here, such perceptions were found to place major constraints on the 
ways  that  some  patients  viewed  their  relationship  with  their  doctors,  and  the  type  of 
information that they were willing to share with them regarding their decisions over treatment 
seeking and consumption. A major issue for patients seeking HIV treatment was the difficulty 
they faced in understanding the treatment choices that were available to them, and their lack 
of confidence in asking doctors who they perceived to have more important issues to attend 
to, to provide information in a language that was more accessible to them. At the same time, 
such difficulties  in  effective  communication  were found to lead to  confusion and anxiety 
when people did not understand why their treatment was being changed, or when they felt that 
the wishes  of  their  doctors  – often assumed to be in  concordance  with wider  biomedical 
health agendas - were being prioritised over their own understandings and health care needs. 
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Although some people reported that they willingly chose to conform to the advice of their 
doctor,  a significant  proportion of people felt  that their  actions – or at least  those actions 
undertaken in public – were constrained by the need to be seen by doctors and other people in 
their  community  to  be  acting  ‘responsibly’  and  adhering  to  the  scientifically  advanced 
treatment opportunities afforded by western biomedicine. While most people expressed their 
faith in ART, the research found that a significant proportion had used, or expressed a wish to 
use,  ‘alternative;  or  ‘traditional’  treatments,  and  as  such,  sought  ways  to  circumvent  the 
monopoly of biomedicine. However, the stigma and secrecy associated with these treatments, 
particularly those obtained from Africa, meant that their use was often surreptitious and was 
rarely discussed openly with health care practitioners. Additionally, for some patients, various 
forms of treatments were considered too natural to be of any possible harm either taken alone 
or with ART, or were considered to be safe because they came in a processed form and/or 
were considered  to  originate  from sources  that  patients  felt  that  their  doctors  would find 
reputable.  Information shared with health  practitioners  was also found to be restricted  by 
patients when they did not consider the (usually herbal) substances that they were taking for 
issues related to aspects of their wellbeing to be of direct consequence to their HIV-related 
health outcomes. 
Many of the issues raised in the present research were undoubtedly influenced to varying 
degrees by respondents’ status as migrants in the UK. While this, and the relatively small 
sample  size  precludes  the  generalisation  of  findings  to  a  wider  population,  the  ease with 
which processes of globalisation now enable people to maintain close social  and material 
links with their home countries suggest that some of the findings may have wider relevance. 
Findings indicate that understandings over what constitutes reputable medical knowledge and 
the perceived legitimacy of different types of treatments can play a potentially important role 
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in  influencing  the  information  that  patients  choose  to  share  with,  or  conceal  from their 
doctors.  In the case of HIV-related health care where certain herbal treatments have been 
found  to  have  the  potential  to  interact  negatively  with  anti-retroviral  treatments,  such 
obstacles  to  effective  communication  between  patients  and  doctors  may  have  adverse 
implications for both individual and public health.
Although it was beyond the remit of this study to explore the views of healthcare providers, it 
is clear that their perceptions of the patient-doctor relationship must be central to any further 
research in this area, so that ways of initiating more effective channels of communication are 
established. Of key importance here is the need to find ways of ensuring that the ‘right’ kinds 
of questions can be asked, which, through recognising the very real discourses and practices 
that  influence  people’s  every  day  lives,  draw  upon  wider  interpretations  of  health  and 
wellbeing than only those contained within biomedical models of understanding. Central to 
this  is  the need for health  care providers to  more  openly acknowledge the wide array of 
treatments that exist outside of the parameters of biomedical science, to recognise not only 
their limitations, but also their potential physiological and psychological benefits to individual 
users, and to proactively seek to ensure that patients are provided with opportunities, and feel 
able, to discuss their use of such treatments without fear of criticism or rebuke. 
At the same time, this paper has demonstrated that agency in health seeking has many, often 
conflicting,  dimensions  beyond  those of  the  biomedical  frameworks  within  which  current 
policy is drawn up. As such, it is important that health workers and policy makers do not 
assume that all patients construct their agency only via the discourse and practices of modern 
biomedicine and that they are able to look beyond viewing people and their bodies in purely 
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medical terms, to foster a wider and more flexible understanding of the ways in which people 
shape their agency and decision making over their health and treatment. 
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i It is recognised that terms and categories such as ‘alternative’ and ‘traditional’ can be seen as problematic since in their 
very nature, they normalise and give precedence to biomedicine. While recognising the heterogeneous, fluctuating and 
overlapping nature of such categories, they are used in this paper as they have become conventionally used terms in the 
UK.
ii Whilst recognising the wide range of cosmologies which exist across and within different countries and regions of 
Africa.
iii Focus groups participants were recruited from community groups and contacts across London, whilst interview 
participants were recruited from one London hospital. There was no overlap between the two groups.  
iv Such actions are linked to the relatively high levels of treatment activism associated with the field of HIV.
v Interview codes are used here to protect participant identity. M refers to male respondents, F to female respondents. 
vi A small number of the youngest focus group participants who had migrated to the UK whilst still children were 
however, less likely to use or want to use African treatments.
vii Although the makers of Mariandina do not claim to be able to cure people of HIV, there was a common perception 
amongst research informants that its use could significantly reduce the likelihood and effects of various HIV-related 
conditions. Testimonies posted at http://www.mariandina.com/index2.htm# also attest such claims. While the author of 
this paper does not know if or how Mariandina products interact with various forms of ART, some of the ingredients 
listed in the products e.g. St. John’s Wort, have been reported to have potentially adverse impacts on the effectiveness 
of certain HIV medications (cf. Mills, Foster, van Heeswijk, Phillips, Wilson, Leonard et al. 2005b).  
viii Mariandina was first produced by a Ugandan doctor, Charles Ssali. A controversial figure, Charles Ssali was 
suspended from the Royal College of Surgeons of Edinburgh in 1992 and publicly rebuked for his claims to have found 
a cure for AIDS (Laurance, 1998). Questions over the efficacy of Mariandina also led to the drugs being banned from 
sale in Uganda although they were later licensed for sale as nutritional supplements (Ariko, 2005). Despite such 
controversy, Ssali remained a popular figure in some quarters until his death, and is still hailed by some as a crusader 
against the monopoly of the pharmaceutical industry.  
